Rong Ding
Impact in
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
- Fungal Biology and Applications
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Pharmacology 13
- Microbial Natural Products and Biosynthesis 7
- Fungal Biology and Applications 4
-
- Metabolomics and Mass Spectrometry Studies 6
- Natural product bioactivities and synthesis 6
- Co-authors
- Dawei Ye (4 shared papers)Ting Lin (10 shared papers)Haifeng Chen (13 shared papers)Hao Gao (4 shared papers)Guanghui Wang (11 shared papers)Hua‐An Wen (2 shared papers)Zhi Li (1 shared paper)Wei Wu (1 shared paper)
- Journals
- Frontiers in Immunology (5 papers)Phytochemistry (3 papers)Chemistry & Biodiversity (3 papers)Analytical Chemistry (2 papers)Bioorganic Chemistry (2 papers)
- Partner nations
- ChinaHong KongUnited Kingdom
In The Last Decade
Rong Ding
88 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 119
- Pharmacology 219
- Hepatology 69
- Obstetrics and Gynecology 59
- Cancer Research 112
- Oncology 200
Countries citing papers authored by Rong Ding
This map shows the geographic impact of Rong Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rong Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rong Ding more than expected).
Fields of papers citing papers by Rong Ding
This network shows the impact of papers produced by Rong Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rong Ding. The network helps show where Rong Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Rong Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 106 | |
| 2 | 2011 | 95 | |
| 3 | 2023 | 80 | |
| 4 | 2018 | 73 | |
| 5 | 2023 | 56 | |
| 6 | 2023 | 54 | |
| 7 | 2020 | 51 | |
| 8 | 2018 | 41 | |
| 9 | 2021 | 41 | |
| 10 | 2023 | 40 | |
| 11 | 2011 | 39 | |
| 12 | 2022 | 37 | |
| 13 | 2023 | 36 | |
| 14 | 2022 | 34 | |
| 15 | 2017 | 33 | |
| 16 | 2020 | 32 | |
| 17 | 2016 | 30 | |
| 18 | 2014 | 26 | |
| 19 | 2018 | 25 | |
| 20 | 2018 | 25 |
About Rong Ding
Rong Ding is a scholar working on Pharmacology, Molecular Biology, Oncology, Hepatology and Complementary and alternative medicine, having authored 92 papers that have together received 1.6k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (7 papers), Metabolomics and Mass Spectrometry Studies (6 papers), Natural product bioactivities and synthesis (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Fungal Biology and Applications (4 papers), Cancer Treatment and Pharmacology (4 papers), Phytochemistry and Biological Activities (4 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Pharmacology (219 citations), Hepatology (69 citations), Obstetrics and Gynecology (59 citations), Cancer Research (112 citations) and Oncology (200 citations). Rong Ding has collaborated with scholars based in China, Hong Kong and United Kingdom. Frequent co-authors include Dawei Ye, Ting Lin, Haifeng Chen, Hao Gao, Guanghui Wang, Hua‐An Wen, Zhi Li, Wei Wu, Tao Wu and Xuan Zhang. Their work appears in journals such as Frontiers in Immunology, Phytochemistry, Chemistry & Biodiversity, Analytical Chemistry and Bioorganic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.